A human study using [123I] β-CIT SPECT on patients with AD found a decrease in DAT availability during the withdrawal period followed by a significant increase after a period of abstinence.[9] The results of that study indicated that DAT availability might be transiently reduced in the alcohol withdrawal state and gradually increased after a period of abstinence. Here, SLC6A3 is linked to Alzheimer disease.